quantum dots
Researchers Developing miRNA-Based Cancer Monitoring Tech for Potential At-Home Liquid Biopsy
Premium
The technology will measure cancer-associated miRNAs using optical amplification with quantum dots and photonic crystals.
Quantum Materials, NanoAxis Partner on Microarray, Drug Development
NEW YORK (GenomeWeb News) – Quantum Materials and NanoAxis have forged a deal combining their technologies for diagnostic and pharmaceutical applications.
Quantum Materials and Nanoaxis this week announced a partnership that will see the firms pair their respective technologies to develop microarray-based tests for a variety of conditions.
Building on its experience in different technology areas, the company is currently developing the single-molecule platform, which it plans to start testing next year with external collaborators such as the J. Craig Venter Institute.
Short Reads: Mar 24, 2009
Premium
Life Technologies, J. Craig Venter Institute, BioNanomatrix, Nanosys, Geospiza, HDF Group, Pressure BioSciences, Cofactor Genomics, Ambry Genetics, Affymetrix, Navigenics, Enzymatics, New York State Department of Health, University of Washington
Jan 28, 2009